Physician profile
Christopher M Busch
NPI 1396165726
$2,456.61
in general payments reported to CMS, 2019-2025
12 companies · $84.28 in 2025
The $84.28 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2021: $1,212 · 2022: $485 · 2023: $300 · 2024: $253 · 2025: $84.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,129.34 | 2021-2023 | |
| Boston Scientific Corporation | $378.13 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Stryker Corporation | $326.61 | 2021-2024 | Omnicurve |
| Globus Medical, INC. | $224.64 | 2022-2025 | Guided Instruments, Creo S2ai, Excelsius3d Imaging System |
| Abbott Laboratories | $127.37 | 2024 | Eterna |
| Depuy Synthes Sales INC. | $75.64 | 2022 | |
| Medtronic, INC. | $56.91 | 2022 | |
| Medtronic USA, INC. | $39.29 | 2019 | |
| Kls-Martin L.P. | $29.14 | 2024 | |
| Microtransponder, INC. | $25.52 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $23.34 | 2025 | |
| Silk Road Medical, INC. | $20.68 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Busch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.